Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10980532rdf:typepubmed:Citationlld:pubmed
pubmed-article:10980532lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C0026847lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C1367790lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C0026609lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C1708726lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C0032520lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C1285573lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C0679932lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C1514433lld:lifeskim
pubmed-article:10980532lifeskim:mentionsumls-concept:C1742737lld:lifeskim
pubmed-article:10980532pubmed:issue3lld:pubmed
pubmed-article:10980532pubmed:dateCreated2000-10-5lld:pubmed
pubmed-article:10980532pubmed:abstractTextPrecise quantitation of SMN1 copy number is of great interest in many clinical applications such as direct detection of SMA carriers or detection of an SMA-affected patient with a hemizygous deletion of the SMN1 gene. We describe a method that combines two independent nonradioactive PCR assays: determination of the relative ratio of the SMN1 and SMN2 genes using a primer extension assay and of the total SMN copy number using competitive PCR. Consistency of the results of two independent approaches ensures the reliability of the deduced genotype and thus avoids false interpretation of borderline results that can occur in quantitative assays. In all, 135 subjects were tested, including 91 normal controls and 44 SMA-affected children or SMA carriers. Two main genotypes were observed in controls: 2T/2C (45%) and 2T/1C (32%). A wide variability at the SMN locus is observed with nine different genotypes and up to six SMN genes. SMA carriers showed three frequent genotypes, 1T/2C (50%), 1T/3C (29%), and 1T/1C (18%). Normal chromosomes with two SMN1 genes per chromosome are not infrequent and thus, about 3% of SMA carriers are not detected using SMN1 copy number quantitation. Finally, as this method does not detect point mutations (4% of SMN1 gene mutations), reliability ranges from 93% to 100% depending on data available from the propositus.lld:pubmed
pubmed-article:10980532pubmed:languageenglld:pubmed
pubmed-article:10980532pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:citationSubsetIMlld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10980532pubmed:statusMEDLINElld:pubmed
pubmed-article:10980532pubmed:monthSeplld:pubmed
pubmed-article:10980532pubmed:issn1098-1004lld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:MayerMMlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:ElionJJlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:EvrardPPlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:GrandchampBBlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:BaumannCClld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:GérardBBlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:MatthijsGGlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:GinerLLlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:Da SilvaFFlld:pubmed
pubmed-article:10980532pubmed:authorpubmed-author:Gérard-Blanlu...lld:pubmed
pubmed-article:10980532pubmed:copyrightInfoCopyright 2000 Wiley-Liss, Inc.lld:pubmed
pubmed-article:10980532pubmed:issnTypeElectroniclld:pubmed
pubmed-article:10980532pubmed:volume16lld:pubmed
pubmed-article:10980532pubmed:ownerNLMlld:pubmed
pubmed-article:10980532pubmed:authorsCompleteYlld:pubmed
pubmed-article:10980532pubmed:pagination253-63lld:pubmed
pubmed-article:10980532pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:meshHeadingpubmed-meshheading:10980532...lld:pubmed
pubmed-article:10980532pubmed:year2000lld:pubmed
pubmed-article:10980532pubmed:articleTitleGenotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension.lld:pubmed
pubmed-article:10980532pubmed:affiliationService de Biochimie Génétique, Hôpital Robert Debré, Paris, France. benedicte.gerard@bch.ap-hop-paris.frlld:pubmed
pubmed-article:10980532pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10980532pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10980532lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10980532lld:pubmed